Purified Myceliophthora laccases and nucleic acids encoding same

ABSTRACT

The present invention relates to isolated nucleic acid constructs containing a sequence encoding a Myceliophthora laccase, and the laccase proteins encoded thereby.

This application is a continuation-in-part of application Ser. No. 08/253,781, filed Jun. 3, 1994 now abandoned, the contents of which are incorporated herein by reference.

FIELD OF THE INVENTION

The present invention relates to isolated nucleic acid fragments encoding a fungal oxidoreductase enzyme and the purified enzymes produced thereby. More particularly, the invention relates to nucleic acid fragments encoding a phenol oxidase, specifically a laccase, of a thermophilic ascomycete, Myceliophthora.

BACKGROUND OF THE INVENTION

Laccases (benzenediol:oxygen oxidoreductases) are multi-copper-containing enzymes that catalyze the oxidation of phenolics. Laccase-mediated oxidations result in the production of aryloxy-radical intermediates from suitable phenolic substrate; the ultimate coupling of the intermediates so produced provides a combination of dimeric, oligomeric, and polymeric reaction products. Such reactions are important in nature in biosynthetic pathways which lead to the formation of melanin, alkaloids, toxins, lignins, and humic acids. Laccases are produced by a wide variety of fungi, including ascomycetes such as Aspergillus, Neurospora, and Podospora, the deuteromycete Botrytis, and basidiomycetes such as collybia, Fomes, Lentinus, Pleurotus, Trametes, and perfect forms of Rhizoctonia. Laccase exhibits a wide range of substrates specificity and each different fungal laccase usually differs only quantitatively from others in its ability to oxidize phenolic substrates. Because of the substrate diversity, laccases generally have found many potential industrial applications. Among these are lignin modification, paper strengthening, dye transfer inhibition in detergents, phenol polymerization, juice manufacture, phenol resin production, and waste water treatment.

Although the catalytic capabilities are similar, laccases made by different fungal species do have different temperature and pH optima, and these may also differ depending on the specific substrate. A number of these fungal laccases have been isolated, and the genes for several of these have been cloned. For example, Choi et al. (Mol. Plant-Microbe Interactions 5: 119-128, 1992) describe the molecular characterization and cloning of the gene encoding the laccase of the chestnut blight fungus, Cryphonectria parasitica. Kojima et al. (J. Biol. Chem. 265: 15224-15230, 1990; JP 2-238885) provide a description of two allelic forms of the laccase of the white-rot basidiomycete Coriolus hirsutus. Germann and Lerch (Experientia 41: 801,1985; PNAS USA 83: 8854-8858, 1986) have reported the cloning and partial sequencing of the Neurospora crassa laccase gene. Saloheimo et al.(J. Gen. Microbial. 137: 1537-1544, 1985; WO 92/01046) have disclosed a structural analysis of the laccase gene from the fungus Phlebia radiata.

Attempts to express laccase genes in heterologous fungal systems frequently give very low yields(Kojima et al., supra; Saloheimo et al., Bio/Technol. 9: 987-990, 1991). For example, heterologous expression of Phlebia radiata laccase in Trichoderma reesei gave only 20 mg per liter of active enzyme(Saloheimo, 1991, supra.). Although laccases have great commercial potential, the ability to express the enzyme in significant quantities is critical to their commercial utility. At the present time there are no laccases which are expressed at high levels in commercially utilized hosts such as Aspergillus. Thus, the need exists for a laccase which can be produced in commercially useful (i.e., gram per liter or more) quantities. The present invention fulfills such a need.

SUMMARY OF THE INVENTION

The present invention relates to a DNA construct containing a nucleic acid sequence encoding a Myceliophthora laccase. The invention also relates to an isolated laccase encoded by the nucleic acid sequence. Preferably, the laccase is substantially pure. By "substantially pure" is meant a laccase which is essentially (i.e.,≧90%) free of other non-laccase proteins.

In order to facilitate production of the novel laccase, the invention also provides vectors and host cells comprising the claimed nucleic acid sequence, which vectors and host cells are useful in recombinant production of the laccase. The sequence is operably linked to transcription and translation signals capable of directing expression of the laccase protein in the host cell of choice. A preferred host cell is a fungal cell, most preferably of the genus Aspergillus. Recombinant production of the laccase of the invention is achieved by culturing a host cell transformed or transfected with the construct of the invention, or progeny thereof, under conditions suitable for expression of the laccase protein, and recovering the laccase protein from the culture.

The laccases of the present invention are useful in a number of industrial processes in which oxidation of phenolics is required. These process include lignin manipulation juice manufacture, phenol polymerization and phenol resin production.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 shows a restriction map of a 7.5 EcoRI fragment in pRaMB1. The region hybridizing to the N. crassa laccase gene probe is shaded.

FIGS. 2A and 2B illustrate the nucleotide(SEQ ID NO: 1) and amino acid (SEQ ID NO: 2) sequence of Myceliophthora thermophila laccase. Lower case letters in the nucleotide sequence indicate the position of introns. Putative TATA and CAAT sequences in the promoter region are in boldface and underlined. Consensus lariat structures(PuCTPuAC)within the introns are underlined.

FIG. 3 illustrates the construction of plasmid pRaMB5.

DETAILED DESCRIPTION OF THE INVENTION

Myceliophthora thermophila is a thermophilic Ascomycete originally described by Apinis (Nova Hedwigia 5: 57-78, 1963) and named Sporotrichum thermophile. Subsequent taxonomic revisions have placed this organism in the genus Chrysosporium (Von Klopotek, A. Arch. Microbial. 98: 365-369, 1974) and later to Myceliophthora (Van Oorschot, Persoonia 9: 401-408, 1977). A number of organisms known by other names also appear to belong to this species. These include Sporotrichum cellulophilum (U.S. Pat. No. 4,106,989); Thielavia thermnophila (Fergus and Sinden, Can. J. Botany 47: 1635-1637, 1968); Chrysosporium fergussi and Corynascus thermophilus (Von Klopotek, supra). This species is known as a source of a number of different industrially useful enzymes, such as cellulases, β-glucosidase and xylanase (see, e.g., Oberson et al., Enzyme Microb. Technol. 14 : 303-312, 1992; Merchant et al., Biotechnol Lett. 10: 513-516, 1988; Breuid et al. Biotechnol. Lett. 8: 673-676, 1986; Gilbert et al., Bioresource Technol. 39: 147-154, 1992). It has now been determined that Myceliophthora produces a neutral pH laccase, and the gene encoding this laccase can be used to produce large yields of the enzyme in convenient host systems such as Aspergillus.

To identify the presence of a laccase gene in Myceliophthora, a 5' portion of the Neurospora crassa laccase gene(lcc1) is used as a probe, under conditions of mild stringency, in southern hybridization of total genomic DNA of different fungal species. An approximately 12 kb laccase specific sequence is detected in the Myceliophthora DNA. The N. crassa fragment is then used to screen about 20,000 plaques of an M. thermophila genomic DNA library in a λ EMBL4 bacteriophage cloning vector. Eight plaques strongly hybridize with the probe; from these eight, DNA is isolated from three. Each of these clones contains a 7.5 EcoRI fragment which also hybridizes to the probe (FIG. 1). One of the fragments is subcloned into pBR322 to generate plasmid pRaMB1. Using the lcc1 probe, the position of the coding region of the clone is determined. The entire M. thermophila coding region appears to be contained with a 3.2 kb NheI-BglII segment, which is then cloned into pUC119 and sequenced by the primer walking method.

Once the sequence is determined, the positions of introns and exons within the gene is assigned based on alignment of the deduced amino acid sequence to the corresponding N. crassa laccase gene product. From this comparison, it appears that the gene (lccM) of M. thermophila is composed of seven exons(246, 79, 12, 70, 973, 69 and 411 nucleotides) interrupted by six introns (85, 84, 102, 72, 147, and 93 nucleotides). The coding region, excluding intervening sequences, is very GC-rich(65.5% G+C) and encodes a preproenzyme of 620 amino acids: a 22 amino acid signal peptide, a 25 amino acid propeptide, and a mature laccase comprising 573 amino acids. The sequence of the M. thermophila gene and the predicted amino acid sequence is shown in FIG. 2 (SEQ ID NOS: 1 and 2).

The laccase gene is then used to create an expression vector for transformation of Aspergillus host cells. The vector, pRaMB5 contains the A. oryzae TAKA-amylase promoter and terminator regions. The construction of pRaMB5 is outlined in FIG. 3. Aspergillus cells are cotransformed with the expression vector and a plasmid containing the pyrG or amdS selectable marker. Transformants are selected on the appropriate selective medium containing ABTS. Laccase-producing colonies exhibit a green halo and are readily isolatable. Selected transformants are grown up in shake flasks and culture broths tested for laccase activity by the syringaldazine method. Shake flask cultures are capable of producing 0.2 or more g/liter of laccase, and in fermentors, yields of over 1-2 g/liter are observed.

According to the invention, a Myceliophthora gene encoding a laccase can be obtained by methods described above, or any alternative methods known in the art, using the information provided herein. The gene can be expressed, in active form, using an expression vector. A useful expression vector contains an element that permits stable integration of the vector into the host cell genome or autonomous replication of the vector in a host cell independent of the genome of the host cell, and preferably one or more phenotypic markers which permit easy selection of transformed host cells. The expression vector may also include control sequences encoding a promoter, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes. To permit the secretion of the expressed protein nucleotides encoding a signal sequence may be inserted prior to the coding sequence of the gene. For expression under the direction of control sequences, a laccase gene to be used according to the invention is operably linked to the control sequences in the proper reading frame. Promoter sequences that can be incorporated into plasmid vectors, and which can direct the transcription of the laccase gene, include but are not limited to the prokaryotic β-lactamase promoter (Villa-Kamaroff, et al., 1978, Proc. Natl. Acad. Sci. U.S.A. 75:3727-3731) and the tac promoter (DeBoer, et al., 1983, Proc. Natl. Acad. Sci. U.S.A. 80:21-25). Further references can also be found in "Useful proteins from recombinant bacteria" in Scientific American, 1980, 242:74-94; and in Sambrook et al., Molecular Cloning, 1989.

The expression vector carrying the DNA construct of the invention may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will typically depend on the host cell into which it is to be introduced. Thus, the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid, or an extrachromosomal element, minichromosome or an artificial chromosome. Alternatively, the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome(s) into which it has been integrated.

In the vector, the laccase DNA sequence should be operably connected to a suitable promoter sequence. The promoter may be any DNA sequence which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell. Examples of suitable promoters for directing the transcription of the DNA construct of the invention, especially in a bacterial host, are the promoter of the lac operon of E.coli, the Streptomyces coelicolor agarase gene dagA promoters, the promoters of the Bacillus licheniformis α-amylase gene (amyL), the promoters of the Bacillus stearothermophilus maltogenic amylase gene (amyM), the promoters of the Bacillus amyloliquefaciens α-amylase (amyQ), or the promoters of the Bacillus subtilis xylA and xylB genes. In a yeast host, a useful promoter is the eno-1 promoter. For transcription in a fungal host, examples of useful promoters are those derived from the gene encoding A. oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, A. niger neutral α-amylase, A. niger acid stable α-amylase, A. niger or A. awamori glucoamylase (glaA), Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase or A. nidulans acetamidase. Preferred are the TAKA-amylase and glaA promoters.

The expression vector of the invention may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably connected to the DNA sequence encoding the laccase of the invention. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter. The vector may further comprise a DNA sequence enabling the vector to replicate in the host cell in question. Examples of such sequences are the origins of replication of plasmids pUC19, pACYC177, pUB110, pE194, pAMB1 and pIJ702.

The vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect in the host cell, such as the dal genes from B.subtilis or B.licheniformis, or, one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracycline resistance. Examples of Aspergillus selection marker include amdS, pyrG, argB, niaD, sC, and hygB, a marker giving rise to hygromycin resistance. Preferred for use in an Aspergillus host cell are the amdS and pyrG markers of A. nidulans or A. oryzae. A frequently used mammalian marker is the dihydrofolate reductase (DHFR) gene. Furthermore, selection may be accomplished by co-transformation, e.g. as described in WO 91/17243.

It is generally preferred that the expression gives rise to a product which is extracellular. The laccases of the present invention may thus comprise a preregion permitting secretion of the expressed protein into the culture medium. If desirable, this preregion may be native to the laccase of the invention or substituted with a different preregion or signal sequence, conveniently accomplished by substitution of the DNA sequences encoding the respective preregions. For example, the preregion may be derived from a glucoamylase or an amylase gene from an Aspergillus species, an amylase gene from a Bacillus species, a lipase or proteinase gene from Rhizomucor miehei, the gene for the α-factor from Saccharomyces cerevisiae or the calf preprochymosin gene. Particularly preferred, when the host is a fungal cell, is the preregion for A. oryzae TAKA amylase, A. niger neutral amylase, the maltogenic amylase form Bacillus NCIB 11837, B. stearothermophilus α-amylase, or Bacillus licheniformis subtilisin. An effective signal sequence is the A. oryzae TAKA amylase signal, the Rhizomucor miehei aspartic proteinase signal and the Rhizomucor miehei lipase signal.

The procedures used to ligate the DNA construct of the invention the promoter, terminator and other elements, respectively, and to insert them into suitable vectors containing the information necessary for replication, are well known to persons skilled in the art (cf., for instance, Sambrook et al. Molecular Cloning, 1989).

The cell of the invention either comprising a DNA construct or an expression vector of the invention as defined above is advantageously used as a host cell in the recombinant production of a enzyme of the invention. The cell may be transformed with the DNA construct of the invention, conveniently by integrating the DNA construct in the host chromosome. This integration is generally considered to be an advantage as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g. by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.

The host cell may be selected from prokaryotic cells, such as bacterial cells. Examples of suitable bacteria are gram positive bacteria such as Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautus, Bacillus megaterium, Bacillus thuringiensis, or Streptomyces lividans or Streptomyces murinus, or gram negative bacteria such as E.coli. The transformation of the bacteria may for instance be effected by protoplast transformation or by using competent cells in a manner known per se.

The host cell may also be a eukaryote, such as mammalian cells, insect cells, plant cells or preferably fungal cells including yeast and filamentous fungi. For example, useful mammalian cells include CHO or COS cells. A yeast host cell may be selected from a species of Saccharomyces or Schizosaccharomyces, e.g. Saccharomyces cerevisiae. Useful filamentous fungi may selected from a species of Aspergillus, e.g. Aspergillus oryzae or Aspergillus niger. Alternatively, a strain of a Fusarium species, e.g. F. oxysporum, can be used as a host cell. Fungal cells may be transformed by a process involving protoplast formation and transformation of the protoplasts followed by regeneration of the cell wall in a manner known per se. A suitable procedure for transformation of Aspergillus host cells is described in EP 238 023. A suitable method of transforming Fusarium species is described by Malardier et al., 1989.

The present invention thus provides a method of producing a recombinant laccase of the invention, which method comprises cultivating a host cell as described above under conditions conducive to the production of the enzyme and recovering the enzyme from the cells and/or culture medium. The medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of the laccase of the invention. Suitable media are available from commercial suppliers or may be prepared according to published formulae (e.g. in catalogues of the American Type Culture Collection).

In a preferred embodiment, the recombinant production of laccase in culture is achieved in the presence of an excess amount of copper. Although trace metals added to the culture medium typically contain a small amount of copper, experiments conducted in connection with the present invention show that addition of a copper supplement to the medium can increase the yield of active enzyme many-fold. Preferably, the copper is added to the medium in soluble form, preferably in the form of a soluble copper salt, such as copper chloride, copper sulfate, or copper acetate. The final concentration of copper in the medium should be in the range of from 0.2-2 mM, and preferably in the range of from 0.05-0.5 mM. This method can be used in enhancing the yield of any recombinantly produced fungal laccase, as well as other copper-containing enzymes, in particular oxidoreductases.

The resulting enzyme may be recovered from the medium by conventional procedures including separating the cells from the medium by centrifugation or filtration, precipitating the proteinaceous components of the supernatant or filtrate by means of a salt, e.g. ammonium sulphate, followed by purification by a variety of chromatographic procedures, e.g. ion exchange chromatography, gel filtration chromatography, affinity chromatography, or the like. Preferably, the isolated protein is about 90% pure as determined by SDS-PAGE, purity being most important in food, juice or detergent applications.

In a particularly preferred embodiment, the expression of laccase is achieved in a fungal host cell, such as Aspergillus. As described in detail in the following examples, the laccase gene is ligated into a plasmid containing the Aspergillus oryzae TAKA α-amylase promoter, and the Aspergillus nidulans amdS selectable marker. Alternatively, the amdS may be on a separate plasmid and used in co-transformation. The plasmid (or plasmids) is used to transform an Aspergillus species host cell, such as A. ozyzae or A. niger in accordance with methods described in Yelton et al. (PNAS USA 81: 1470-1474,1984).

Those skilled in the art will recognize that the invention is not limited to use of the nucleic acid fragments specifically disclosed herein, for example, in FIG. 1. It will also be apparent that the invention encompasses those nucleotide sequences that encode the same amino acid sequences as depicted in FIG. 1, but which differ from the specifically depicted nucleotide sequences by virtue of the degeneracy of the genetic code. Also, reference to FIG. 1 in the specification and the claims will be understood to encompass both the genomic sequence depicted therein as well as the corresponding cDNA and RNA sequences, and the phrases "DNA construct" and "nucleic acid sequences" as used herein will be understood to encompass all such variations. "DNA construct" shall generally be understood to mean a DNA molecule, either single- or double-stranded, which may be isolated in partial form from a naturally occurring gene or which has been modified to contain segments of DNA which are combined and juxtaposed in a manner which would not otherwise exist in nature.

The Myceliophthora laccase described herein has a particularly high specific activity on a syringaldazine substrate relative to other known ascomycete or deuteromycete extracellular laccases in which such specific activity has been described. The present sequence provides a means by which other such ascomycete and/or deuteromycete laccases can also be isolated. Identification and isolation of laccase genes from sources other than those specifically exemplified herein can be achieved by utilization of the methodology described in the present examples, with publicly available ascomycete and deuteromycete strains. In particular, the specific sequence disclosed herein can be used to design primers and/or probes useful in isolating similar laccase genes by standard PCR or southern hybridization techniques. The present invention thus encompasses those ascomycete and deuteromycete laccases which have a specific activity of at least about 30 SOU/mg. and preferably at least about 40 SOU/mg, "SOU" being defined as μmol of substrate oxidized per minute as measured with syringaldazine as a substrate, at optimum pH.

In addition, the invention also encompasses other Myceliophthora laccases, including alternate forms of laccase which may be found in M. thermophila and as well as laccases which may be found in other fungi falling within the definition of Myceliophthora as defined by Van Oorschot, 1977, supra. Identification and isolation of laccase genes from sources other than those specifically exemplified herein can be achieved by utilization of the methodology described in the present examples, with publicly available Myceliophthora strains. Alternately, the sequence disclosed herein can be used to design primers and/or probes useful in isolating laccase genes by standard PCR or southern hybridization techniques. Other named Myceliophthora species include Myceliphthora hinnulea (Awao et al., Mycotaxon. 16: 436-440, 1983), Myceliophthora vellerea (Guarro et al, Mycotaxon. 23: 419-427, 1985), and Myceliophthora lutea Costatin. Also encompassed are laccases which are synonyms, e.g., anamorphs or perfect states of species or strains of the genus Myceliophthora. Strains of Myceliophthora are readily accessible to the public in a number of culture collections, such as ATCC 48102, 48103, 48104 et al.; CBS 117.65, 131.65, 379.65 et al., DSM 1799 (M. thermophila), ATCC 52474, CBS 539.82, 540.82 et al. (M. hinnulea), DSM 62114, CBS 146.50, 147.50, 157.51 et al (M. lutea), and CBS 478.76, 479.76 and 715.84(M. vellerea). The invention also encompasses any variant nucleotide sequence, and the protein encoded thereby, which protein retains at least about an 80%, preferably at least 85%, and most preferably at least 90-95% homology with the amino acid sequence depicted in FIG. 2, and which qualitatively retains the laccase activity of the sequence described herein. Useful variants within the categories defined above include, for example, ones in which conservative amino acid substitutions have been made, which substitutions do not significantly affect the activity of the protein. By conservative substitution is meant that amino acids of the same class may be substituted by any other of that class. For example, the nonpolar aliphatic residues Ala, Val, Leu, and Ile may be interchanged, as may be the basic residues Lys and Arg, or the acidic residues Asp and Glu. Similarly, Ser and Thr are conservative substitutions for each other, as are Asn and Gln. It will be apparent to the skilled artisan that such substitutions can be made outside the regions critical to the function of the molecule and still result in an active enzyme. Retention of the desired activity can readily be determined by conducting a standard ABTS oxidation method, such as is described in the present examples.

The protein can be used in number of different industrial processes. These processes include polymerization of lignin, both Kraft and lignosulfates, in solution, in order to produce a lignin with a higher molecular weight. A neutral/alkaline laccase is a particular advantage in that Kraft lignin is more soluble at higher pHs. Such methods are described in, for example, Jin et al., Holzforschung 45(6): 467-468, 1991; U.S. Pat. No. 4,432,921; EP 0 275 544; PCT/DK93/00217, 1992.

The laccase of the present invention can also be used for in-situ depolymerization of lignin in Kraft pulp, thereby producing a pulp with lower lignin content. This use of laccase is an improvement over the current use of chlorine for depolymerization of lignin, which leads to the production of chlorinated aromatic compounds, which are an environmentally undesirable by-product of paper mills. Such uses are described in, for example, Current opinion in Biotechnology 3: 261-266, 1992; J. Biotechnol. 333-339, 1992; Hiroi et al., Svensk papperstidning 5: 162-166, 1976. Since the environment is more useful for this purpose than the present laccase is more useful for this purpose chain other known laccases, which function best under acidic conditions.

Oxidation of dyes or dye precursors and other chromophoric compounds leads to decolorization of the compounds. Laccase can be used for this purpose, which can be particularly advantageous in a situation in which a dye transfer between fabrics is undesirable, e.g., in the textile industry and in the detergent industry. Methods for dye transfer inhibition and dye oxidation can be found in WO 92/01406; WO 92/18683; EP 0495836; Calvo, Mededelingen van de Faculteit Landbouw-wetenschappen/Rijiksuniversitet Gent.56: 1565-1567, 1991; Tsujino et al., J. Soc. Chem.42: 273-282, 1991.

The laccase is particularly well-suited for use in hair dyeing. In such an application, the laccase is contacted with a dye precursor, preferably on the hair, whereby a controlled oxidation of the dye precursor is achieved to convert the precursor to a dye, or pigment producing compound, such as a quinoid compound. The dye precursor is preferably an aromatic compound belonging to one of three major chemical families: the diamines, aminophenols(or aminonaphthols) and the phenols. The dye precursors can be used alone or in combination. At least one of the intermediates in the copolymerization must be an ortho- or para-diamine or aminophenol(primary intermediate). Examples of such are found in Section IV, below, and include p-phenylene-diamine(pPD), p-toluylene-diamine, chloro-p-phenylenediamine, p-aminophenol, o-aminophenol. 3,4-diaminotoluene; additional compounds are also described in U.S. Pat. No. 3,251,742, the contents of which are incorporated herein at reference. In one embodiment, the starting materials include not only the enzyme and a primary intermediate, but also a modifier(coupler) (or combination of modifiers), which modifier is typically a meta-diamine, meta-aminophenol, or a polyphenol. Examples of modifier compounds include m-phenylene-diamine, 2,4-diaminoanisole, α-naphthol, hydroquinone, pyrocatechol, resorcinol, and 4-chlororesorcinol. The modifier then reacts with the primary intermediate in the presence of the laccase, converting it to a colored compound. In another embodiment, the laccase can be used with the primary intermediate directly, to oxidize it into a colored compound. In all cases, the dyeing process can be conducted with one or more primary intermediates, either alone or in combination with one or more modifiers. Amounts of components are in accordance with usual commercial amounts for similar components, and proportions of components may be varied accordingly.

The use of this laccase is an improvement over the more traditional use of H₂ O₂, in that the latter can damage the hair, and its use usually requires a high pH, which is also damaging to the hair. In contrast, the reaction with laccase can be conducted at alkaline, neutral or even acidic pH, and the oxygen needed for oxidation comes from the air, rather than via harsh chemical oxidation. The result provided by the use of the Myceliophthora laccase is comparable to that achieved with use of H₂ O₂, not only in color development, but also in wash stability and light fastness. An additional commercial advantage is that a single container package can be made containing both the laccase and the precursor, in an oxygen free atmosphere, which arrangement is not possible with the use of H₂ O₂.

The present laccase can also be used for the polymerization of phenolic compounds present in liquids. An example of such utility is the treatment of juices, such as apple juice, so that the laccase accelerate a precipitation of the phenolic compounds present in the juice, thereby producing a more stable juice. Such applications have been described in Stutz, Fruit processing 7/93, 248-252, 1993; Maier et al., Dt. Lebensmittel-rindschau 86(5): 137-142, 1990; Dietrich et al., Fluss. obst 57(2): 67-73, 1990,.

Laccases such as the Myceliophthora laccase are also useful in soil detoxification (Nannipieri et al., J. Environ. Qual. 20: 510-517,1991; Dec and Bollag, Arch. Environ. Contam. Toxicol. 19: 543-550, 1990).

The invention is further illustrated by the following non-limiting examples.

EXAMPLES I. ISOLATION OF MYCELIOPHTHORA THERMOPHILA LACCASE GENE

A. MATERIALS AND METHODS

1. DNA Extraction and Hybridization analysis

Total cellular DNA is extracted from fungal cells of Myceliophthora thermophila strain E421 grown 24 hours in 25 ml of YEG medium (0.5% yeast extract, 2% glucose) using the following protocol: mycelia are collected by filtration through Miracloth (Calbiochem) and washed once with 25 ml of TE buffer. Excess buffer is drained from the mycelia which are subsequently frozen in liquid nitrogen. Frozen mycelia are ground to a fine powder in an electric coffee grinder,and the powder added to 20 ml of TE buffer and 5 ml of 20% SDS (w/v) in a disposable plastic centrifuge tube. The mixture is gently inverted several times to ensure mixing, and extracted twice with an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1. Sodium acetate (3M solution) is added to give a final concentration of 0.3M and the nucleic acids are precipitated with 2.5 volumes of ice cold ethanol. The tubes are centrifuged at 15,000×g for 30 minutes and the pellet is allowed to air-dry for 30 minutes before resuspending in 0.5 ml of TE buffer. DNase-free ribonuclease A is added to a concentration of 100 μg/ml and the mixture is incubated at 37° C. for 30 minutes. Proteinase K (200 μg/ml) is added and each tube is incubated an additional one hour at 37° C. Finally, each sample is extracted twice with phenol:chloroform:isoamyl alcohol before precipitating the DNA with sodium acetate and ethanol. DNA pellets are dried under vacuum, resuspended in TE buffer, and stored at 4° C.

Total cellular DNA samples from transformants and an untransformed control strain are analyzed by Southern hybridization. Approximately 5 μg of DNA is digested with EcoRI and fractionated by size on a 1% agarose gel. The gel is photographed under short wavelength IT and soaked for 15 minutes in 0.5M NaOH, 1.5M NaCl followed by 15 minutes in 1M Tris-HCl, pH 8, 1.5M NaCl. DNA in the gel is transferred onto Zeta-Probe™ hybridization membrane (BioRad Laboratories) by capillary blotting in 20×SSPE (R. W. Davis et al., Advanced Bacterial Genetics, A Manual for Genetic Engineering. Cold Spring Harbor Press. 1980) Membranes are baked for 2 hours at 80° C. under vacuum and soaked for 2 hours in the following hybridization buffer at 45° C. with gentle agitation: 5×SSPE, 35% formamide (v/v), 0.3% SCS, 200 μg/ml denatured and sheared salmon testes DNA. The laccase-specific probe fragment (approx. 1.5 kb) encoding the 5'-portion of the N. crassa lcc1 gene is amplified from N. crassa genomic DNA using standard PCR conditions (Perkin-Elmer Cetus, Emeryville, Calif.) with the following pair of primers: forward primer, 5' CGAGACTGATAACTGGCTTGG 3'; reverse primer, 5' ACGGCGCATTGTCAGGGAAGT 3'. The amplified DNA segment is first cloned into a TA-cloning-vector (Invitrogen Inc. San Diego, Calif.), then purified by agarose gel electrophoresis following digestion with EcoRI. The purified probe fragment is radiolabeled by nick translation with α ³² P!dCTP(Amersham) and added to the hybridization buffer at an activity of approximately 1×10⁶ cpm per ml of buffer. The mixture is incubated overnight at 45° C. in a shaking water bath. Following incubation, the membranes are washed once in 0.2×SSPE with 0.1% SDS at 45° C. followed by two washes in 0.2×SSPE(no SDS) at the same temperature. The membranes are allowed to dry on paper towels for 15 minutes, then wrapped in Saran Wrap™ and exposed to x-ray film overnight at -70° C. with intensifying screens(Kodak).

2. DNA Libraries and Identification of Laccase Clones

Genomic DNA libraries are constructed in the bacteriophage cloning vector λ-EMBL4(J. A. Sorge, in Vectors, A Survey of Molecular Cloning Vectors and Their Uses, Rodriguez et al., eds, pp.43-60, Butterworths, Boston, 1988). Briefly, total cellular DNA is partially digested with Sau3A and size-fractionated on low-melting point agarose gels. DNA fragments migrating between 9 kb and 23 kb are excised and eluted from the gel using β-agarase (New England Biolabs, Beverly Mass.). The eluted DNA fragments are ligated with BamHI-cleaved and dephosphorylated λ-EMBL4 vector arms, and the ligation mixtures are packaged using commercial packaging extracts (Stratagene, LaJolla, Calif.). The packaged DNA libraries are plated and amplified on Escherichia coli K802 cells. Approximately 10,000-20,000 plaques from each library are screened by plaque-hybridization with the radiolabeled lcc1 DNA fragment using the conditions described above. Plaques which give hybridization signals with the probe are purified twice on E. coli K802 cell, and DNA from the corresponding phage is purified from high titer lysates using a Qiagen Lambda kit(Qiagen, Inc., Chatsworth, Calif.)

3. Analysis of Laccase Genes

Restriction mapping of laccase clones is done using standard methods (Lewin, Genes. 2d ed., Wiley & Sons, 1985, New York). DNA sequencing is done with an Applied Biosystems Model 373A automated DNA Sequencer (Applied Biosystems, Inc., Foster City, Calif.) using the primer walking technique with dye-terminator chemistry (H. Giesecke et al., J. Virol. Methods 38: 47-60, 1992). Oligonucleotide sequencing primers are synthesized on an Applied Biosystems model 394 DNA/RNA Synthesizer.

B. RESULTS AND DISCUSSION

1. Identification of Laccase Gene Sequence

Total cellular DNA samples are prepared from the species Neurospora crassa, Botrytis cinerea, and Myceliophthora. Aliquots of these DNA preparations are digested with BamHI and fractionated by agarose gel electrophoresis. DNA in the gel is blotted to a Zeta-Probe™ membrane filter (BioRad Laboratories, Hercules, Calif.) and probed under conditions of mild stringency with a radiolabeled fragment encoding a portion of the N. crassa lcc1 gene, as described above. Laccase-specific sequences are detected in the genomes of M. thermophila and the N. crassa control, but not in the B. cinerea genomic DNA with this probe.

2. Cloning and Characterization of Myceliophthora thermophila Laccase (MtL) Gene

Approximately 20,000 plaques from a M. thermophila genomic DNA library constructed in a λ-EMBL4 cloning vector are screened. The library is composed of approximately 10,000 independent clones with inserts ranging in size from 9 kb to 23 kb. Assuming an average insert size of 10 kb and a total genome size of 4×10⁷ bp for M. thermophila, this figure is about 2.5 times the number of clones required to represent the entire genome. Eight plaques are identified that hybridized strongly to the N. crassa laccase gene probe. DNA is isolated from three of these, cleaved with EcoRI and analyzed by agarose gel electrophoresis and Southern hybridization. All three of these clones contain a 7.5 kb EcoRI fragment which hybridized to the laccase-specific probe. One of these EcoRI fragments is subcloned into pBR322 (Bolivar et al., Gene 2: 95-113, 1977) to generate plasmid pRaMB1. A restriction map of this DNA segment is shown in FIG. 1. The position of the laccase coding region on this clone is determined by hybridization with the lcc1 gene fragment described above. Based on mapping data obtained, and an estimated size of the laccase protein of approximately 80 kdal, it is reasoned that the entire M. thermophila laccase coding region is contained with a 3.2 kb NheI-BglII segment which is then subcloned into pUC119(Viera and Messing, Methods Enzymol. 153: 3-11, 1987). The nucleotide sequence of this segment is determined using the primer walking method(Giesecke et al., supra). The nucleic acid sequence is shown in FIG. 2 and SEQ ID NO: 1.

The deduced amino acid sequence of MtL is obtained on the basis of amino acid sequence homology with the N. crassa laccase. At the amino acid level, these two laccases share approximately 60% sequence identity. Similarity is highest in regions that correspond to the four histidines and one cysteine which are involved in the formation of the trinuclear copper cluster(Perry et al., J. Gen. Microbiol. 139: 1209-1218, 1993; Coll et al. Appl. Environ. Microbial. 59: 4129-4135, 1993; Messerschmidt et al J. Mol. Biol 206: 513-530, 1989). There are 11 potential sites for N-linked glycosylation in the deduced amino acid sequence of MtL the first 22 amino acids of MtL appear to comprise a canonical signal peptide with a predicted cleavage following an Ala residue (vonHeijne,J.Mol. Biol. 173:243-251, 1984). Although the amino terminal sequence of the native MtL is unknown, the amino terminus of recombinant MtL produced in A. ozyzae is blocked with a pyro-glutamate residue. Enzymatic removal of this residue followed by amino acid sequencing suggests that mature MtL begins with a Gln residue (position 1 in FIG. 2; SEQ ID NO: 2). Thus, MtL is apparently synthesized as a 620 amino acid preproenzyme having a 22 amino acid signal peptide and propeptide of 25 residues. Neurospora crassa laccase(NcL) is processed similarly at its amino terminal end. In addition, NcL is also proteolytically processed at its C-terminus, resulting in the removal of 13 amino acids (Germann et al. J. Biol. Chem. 263: 885-896, 1988). The processing site is contained within the sequence Asp-Ser-Gly-Leu*Arg₅₅₈ (where * designates the cleavage site). A similar sequence exists near the C-terminal end of MtL(Asp-Ser-Gly-Leu-Lys₅₆₀), suggesting the Myceliophthora enzyme may also be subject to C-terminal processing (Asp-Ser-Gly-Leu*Lys560) which would remove 12 amino acids.

The positions of six introns (85, 84, 102, 72, 147, and 93 nucleotides) within the lcc1 coding region are determined by comparing the deduced amino acid sequence of MtL to that of NcL and by applying the consensus rules for intron features in filamentous fungi (Gurr et al., in Gene Structure in Eukaryotic Microbes, J. R. Kinghorn, ed.) pp 93-139, IRL Press, Oxford, 1987). The 1860 nucleotides of coding sequence, excluding introns, are rich in guanosine and cytosine (65.5% GC . The codon usage pattern for this gene reflects the DNA base composition in a strong bias(89.7%) for codons ending in G or C.

II. EXPRESSION OF MYCELIOPHTHORA LACCASE IN ASPERGILLUS

A. MATERIALS AND METHODS

1. Bacterial and Fungal Host Strains

Escherichia coli JM101(Messing et al., Nucl. Acids Res. 9:309-321, 1981) is used as a host for construction and routine propagation of laccase expression vectors in this study. Fungal hosts for laccase expression included the Aspergillus niger strains Bo-1, AB4.1 and AB1.13(Mattern et al., Mol. Gen. Genet. 234: 332-336), as well as a uridine-requiring(pyrG) mutant of the α-amylase-deficient Aspergillus oryzae strain HowB104.

2. Plasmids

Plasmid pRaMB2 is a pUC119 derivative which contains a 3.2 kb BglII-NheI fragment of M. thermophila genomic DNA encoding MtL. The vector pMWR is constructed by inserting the A. oryzae TAKA-amylase promoter and terminator elements from pTAKA17(Christensen et al., Bio/Technol. 6: 1419-1422, 1988; EP 238 023) into pUC18(Yanisch-Perron et al., Gene 33: 103-119, 1985). In this vector, there is a unique SwaI site at the end of the promoter element and a single NsiI site at the beginning of the terminator for directional cloning of coding sequences. The cloning vehicle pUC518 is derived by inserting a small linker containing NsiI, ClaI, XhoI, and BglII restriction sites between the adjacent BamHI and XbaI sites of pUC118(Vieira and Messing, supra). Plasmid pToC68(WO 91/17243) contains the A. oryzae TAKA-amylase promoter and A. niger glaA terminator, and pToC90(WO 25 91/17243) carries the A. nidulans amdS gene.

3. Construction of Laccase Expression Vectors

The construction strategy for the laccase expression vector pRaMB5 is outlined in FIG. 3. The promoter directing transcription of the laccase gene is obtained from the A. oryzae αamylase (TAKA-amylase) gene (Christensen et al., supra), as well as the TAKA-amylase terminator region. The plasmid is constructed first by modifying pMWR3 by inserting a small linker which contains an ApaI site between the SwaI and NsiI sites, creating a plasmid called pMWR3-SAN. PfuI polymerase-directed PCR (Stratagene, La Jolla, Calif.) is used to amplify a short DNA segment encoding the 5'-portion of MtL, from the start codon to an internal PstI site (approximately 0.5 kb). The forward primer for this PCR reaction is designed to create an EcoRI site just upstream of the start codon. Next, the amplified fragment is digested with EcoRI and PstI during this step, the EcoRI site is made blunt by treatment with dNTPs and DNA polymerase I(Klenow fragment)! and purified by agarose gel electrophoresis. The 3' portion of the M. thermophila coding region is excised from pRaMB2 as a 2 kb PstI-ApaI fragment(this segment also contains approximately 110 bp from the 3'-untranslated region). These two fragments are combined with SwaI- and ApaI-cleaved pMWR3-SAN in a three-part ligation reaction to generate the laccase expression vector pRaMB5.

4. Transformation of Aspergillus host cells

Methods for co-transformation of Aspergillus strains are as described in Christensen et al., supra. For introduction of the laccase expression vectors into A. oryzae HowB 104 pyrG, equal amounts (approximately 5 μg each) of laccase expression vector and one of the following plasmids are used: pPYRG (Fungal Genetics Stock Center, Kansas City, Kans.) which contains the A. nidulans pyrG gene(Oakley et al, Gene 61385-399, 1987); pSO2 which harbors the clones A. oryzae pyrG gene; pPRYG24 which contains the A. ficuum(=A. niger)pyrG gene Protrophic(Pyr+) transformants are selected on Aspergillus minimal medium (Rowlands and Turner, Mol. Gen. Genet. 126: 201-216, 1973), and the transformants are transformants are screened for the ability to produce laccase on minimal medium containing 1 mM 2,2'-azinobis(3-ethylbenzthiazolinesulfonic acid) ABTS!. Cells which secrete active laccase oxidize the ABTS, producing a green halo surrounding the colony. Lastly, A. niger Bo-1 protoplasts are co-transformed using equal amounts (approximately 5 μg each) of laccase expression vector and pToC90 which contains the A. nidulans amdS (acetamidase) gene (Hynes et al., Mol. Cell Biol. 3: 1430-1439, 1983. AmdS+ transformants are selected on Cove minimal medium (Cove, Biochim. Biophys. Acta 113: 51-56, 1966) with 1% glucose as the carbon source and acetamide as the sole nitrogen source and screened for laccase expression on cove medium with 1 mM ABTS.

5. Analysis of Laccase-Producing Transformants

Transformants which produce laccase activity on agar plates are purified twice through conidiospores and spore suspensions in sterile 0.01% Tween-80 are made from each. The density of spores in each suspension is estimated spectrophotometrically (A₅₉₅ nm). Approximately 0.5 absorbance units of spores are used to inoculate 25 ml of ASPO4 or MY50 medium in 125 ml plastic flasks. The cultures are incubated at 37° C. with vigorous aeration (approximately 200 rpm) for four to five days. Culture broths are harvested by centrifugation and the amount of laccase activity in the supernatant is determined using syringaldazine as a substrate. Briefly, 800 μl of assay buffer (25 mM sodium acetate, pH 5.5, 40 μM CuSo₄) is mixed with 20 μl of culture supernatant and 60 μl of 0.28 mM syringaldazine (Sigma Chemical Co., St. Louis, Mo.) in 50% ETOH. The absorbance at 530 nm is measured over time in a Genesys 5 UV-vis specrophotometer (Milton-Roy). One laccase unit(LACU) is defined as the amount of enzyme which oxidizes one μmole of substrate per minute at room temperature. SDS-polyacrylamide gel electrophoresis(PAGE) is done using precast 10-27% gradient gels from Novex(San Diego, Calif.). Protein bands are developed using Coomassie Brilliant Blue(Sigma).

B. RESULTS AND DISCUSSION

1. Expression of Myceliophthora laccase

Laccase-producing transformants are detected by incorporation of ABTS into selective media. Using pyrG or amdS as the selectable marker, co-transformation frequencies vary from about 30% to 70%. Heterologous expression of MtL appears to be highest in A. ozyzae transformants. Furthermore, production appears to be better in ASPO4 medium compared to MY50, although the reasons for this are unknown. SDS-PAGE analysis of culture broth samples shows a prominent laccase band at approximately 80 kdal, which is similar to the size of the native enzyme purified from M. thermophila. Similar analysis of the culture filtrates from A. niger Bo-transformants indicate that the laccase band is obscured by very intense glucoamylase and acid-stable amylase protein bands. Results are shown in Table 1.

                  TABLE 1                                                          ______________________________________                                         MtL expression among selected A. oryzae and A. niger transformants             HOST            TRANSFORMING MTLACU/ML                                         STRAIN TRANSFORMANT DNAS         ASPO4 MY50                                    ______________________________________                                         A. oryzae                                                                             untransformed                                                                               none         0.00  0.00                                    HowB104                                                                               RaMB5.15     pRaMB5 + pPYRG                                                                              0.85  0.29                                    pyrG   RaMB5.30     pRaMB5 + pPYRG                                                                              0.71  0.87                                           RaMB5.33     pRaMB5 + PPYRG                                                                              0.60  0.26                                           RaMB5.108    pRaMB5 + PSO2                                                                               0.68  0.19                                           RaMB5.111    pRaMB5 + PSO2                                                                               0.70  0.17                                           RaMB5.121    pRaMB5 + PSO2                                                                               0.49  0.20                                           RaMB5.142    pRaMB5 + PSO2                                                                               0.54  0.04                                    A. Niger                                                                              untransformed                                                                               none         0.00  0.00                                    Bo-1   RaMB5.1      pRaMB5 + pToC90                                                                             n.d.  0.20                                           RaMB5.25     pRaMB5 + pToC90                                                                             n.d.  0.09                                           RaMB5.49     pRaMB5 + pToC90                                                                             n.d.  0.06                                           RaMB5.51     pRaMB5 + pToC90                                                                             n.d.  0.12                                           RaMB5.53     pRaMB5 + pToC90                                                                             n.d.  0.21                                           RaMB5.62     pRaMB5 + pToC90                                                                             n.d.  0.16                                    ______________________________________                                          n.d. = not determined                                                    

2. Expression in the presence or absence of excess copper

A 1 ml aliquot of a spore suspension of Aspergillus oryzae transformant HowB104-pRaMB5.30(approximately 10⁹ spores/ml) is added aseptically to a 500 ml shake flask containing 100 ml of sterile shake flask medium (maltose, 50 g/l; MgSO₄.7H₂ O, 2 g/l; KH₂ PO₄, 10 g/l; K₂ SO₄, 2 g/l; CaCl₂.2H₂ O 0.5 g/l; Citric acid, 2 g/l; yeast extract, 10 g/l; trace metals ZnSO₄.7H₂ O, 14.3 g/l; CuSO₄.5H₂ O, 2.5 g/l; NiCl₂.6H₂ O, 0.5 g/l; FeSO₄.7H₂ O, 13.8 g/l, MnSO₄.H₂ O, 8.5 g/l; citric acid, 3.0 g/l!, 0.5 ml/l; urea, 2 g/l, made with tap water and adjusted to pH 6.0 before autoclaving), and incubated at 37° C. on a rotary shaker at 200 rpm for 18 hours. 50 ml of this culture is aseptically transferred to a 3 liter fermentor containing 1.8 liters of the fermentor media (MgSO₄.7H₂ O, 2 g/l; KH₂ PO₄, 2 g/l; citric acid 4 g/l; K₂ SO₄, 3 g/l;CaCl₂.2H₂ O, 2 g/l; trace metals, 0.5 ml/l; pluronic antifoam, 1 ml/l). The fermentor temperature is maintained at 34° C. by the circulation of cooling water through the fermentor jacket. Sterile air is sparged through the fermentor at a rate of 1.8 liter/min (1 v/v/m). The agitiation rate is maintained between 600 and 1300 rpm at approximately the minimum level required to maintain the dissolved oxygen level in the culture above 20%. Sterile feed (Nutriose 725 maltose syrup!, 225 g/l; urea, 30 g/l; yeast extract, 15 g/l; pluronic antifoam, 1.5 ml/l, made up with distilled water and autoclaved) is added to the fermenter by use of a peristaltic pump. The feed rate profile during the fermentation is as follows: 30 g of feed is added initially before inoculation; 0-24 h, 2 g/l h; 24-48 h, 4 g/l h, 48 h-end, 6 g/l.

Copper is made as a 400X stock in water or a suitable buffer, filter sterilized and added aseptically to the tank to a final level of 0.5 mM. The fermentation described above is also conducted without the addition of copper supplement to tha tank medium. Samples for enzyme activity determination are withdrawn and filtered through Miracloth to remove mycelia. These samples are assayed for laccase activity by the LACU assay described above. Laccase activity is found to increase continuously during the course of the fermentation, with a value of approximately 45 LACU/ml achieved after 180 hours in the fermentation 10 containing excess copper. At a specific activity of 22 LACU/mg, this corresponds to 2 g/l of recombinant laccase expressed. On the other hand, the maximum laccase activity achieved in the fermentation without copper supplement is approximately 10 LACU/ml after 170 hours, or about 25% of that found in the presence of additional copper.

III. PURIFICATION AND CHARACTERIZATION OF MYCELIOPTHORA LACCASE

A. MATERIALS AND METHODS

1. Materials

Chemicals used as buffers and substrates are commercial products of at least reagent grade. Endo/N-glycosidase F and pyroglutamate amino peptidase are purchased from Boehringer Mannheim. Chromatography is performed on either a Pharmacia FPLC or a conventional low pressure system. Spectroscopic assays are conducted on either a spectrophotometer(Shimadzu PC160) or a microplate reader(Molecular Devices). Britton & Robinson(B&R) buffers are prepared according to the protocol described in Quelle, Biochemisches Taschenbuch, H. M. Raven, II. Peil, S.93 u. 102, 1964.

2. Enzymatic Assay

Laccase activity is determined by syringaldazine oxidation at 30° C. in a 1-cm quartz cuvette. 60 μl syringaldazine stock solution (0.28 mM in 50% ethanol) and, 20 μl sample are mixed with 0.8 ml preheated buffer solution. The oxidation is monitored at 530 nm over 5 minutes. The activity is expressed as μmole substrate oxidized per minute. B&R buffers with various pHs are used. The activity unit is referred to here as "SOU". A buffer of 25 mM sodium acetate, 40 μM CuSO₄. pH 5.5, is also used to determine the activity, which is referred to as LACU, as defined above. 2,2'-azinobis(3-ethylbenzo thiazoline-6-sulfonic acid) (ABTS) oxidation assays are done using 0.4 mM ABTS, B&R buffer, pH 4.1, at room temperature by monitoring ΔA₄₀₅. An ABTS oxidase activity overlay assay is performed by pouring cooled ABTS-agarose(0.05 g ABTS, 1 g agarose, 50 ml H₂ O, heated to dissolve agarose) over a native IEF gel and incubating at room temperature. Thermostability analysis of the laccase(r-MtL) is performed using samples that have 3 SOU activity pre-incubated in B&R buffer, pH 6, at various temperatures. Samples are assayed after a 400-fold dilution into the same buffer at room temperature.

3. Purification from a fermentor broth

3.7 liters of cheese-cloth filtered broth (pH 7.6, 16 mS) is filtered through Whatman #2 filter paper. The broth is concentrated on a Spiral Concentrator (Amicon) with a S1Y100 membrane (MWCO:100) from 3700 ml to 200 ml. The concentrate is adjusted to 0.75 mS by diluting it in water and reconcentrated on S1Y100 to 170 ml. The washed and concentrated broth has a dense greenish color.

The broth is frozen overnight at -20° C., thawed the next day and loaded onto a Q-sepharose XK26 column (120 ml), pre-equilibrated with 10 mM Tris, pH 7.5, 0.7 mS(Buffer A). The blue laccase band migrates slowing down the column during loading. One group of blue fractions runs through the column after loading and washing by Buffer A. A second group eluted during the linear gradient with Buffer B (Buffer A plus 2M NaCl). Some brown material with no laccase activity is eluted out later with 1M NaOH. SDS-PAGE analysis shows that this preparation results in pure laccase.

4. Analyses of amino acid content, extent of glycosylation, and N-terminal sequence

N-terminal sequencing is performed on an ABI 476A sequencer. Total amino acid analysis, from which the extinction coefficient of r-MtL is determined, is performed on a HP AminoQuant instrument. Deglycosylation is done using endo/N-glucosidase F according to the manufacturer's instructions and carbohydrate content is estimated by mobility difference as determined on SDS-PAGE. N-terminus de-blocking with pyroglutamate amino peptidase is carried out according to manufacturer's instructions. About 80 μg r-MtL is treated with 4 μg peptidase with or without the presence of 1M urea or 0.1M guanidine HCl before being blotted on a PVDF membrane for sequencing. About 20 pmol de-blocked protein is obtained and sequenced.

SDS-PAGE and native IEF analysis are performed on either a Novex cell or a Mini Protean II and a Model 111 Mini IEF cells (Bio-Rad). Gel filtration analyses are done on a Sephacryl S-300(Pharmacia), from which the native MW is estimated by using Blue Dextran (2000 kdal), bovine IgG (158 kdal), bovine serum albumin (66 kdal), ovalbumin (45 kdal) and horse heart myoglobin(17 kdal) to calibrate the column.

B. RESULTS AND DISCUSSION

1. Purification and characterization of r-MtL from a fermentor broth

From 3.7 l of fermentor broth, about 2-3 g of r-MtL are isolated, initial concentration using a membrane with MWCO of 100 kdal removed significant amounts of brown material and small contaminant proteins. The low affinity of r-MtL toward Q-Sepharose matrix equilibrated with 10 mM Tris, pH 7.5, facilitates its separation from other more acidic and more tightly bound impurities. As shown by SDS-PAGE, this preparation resulted in essentially pure laccase for the most active fractions located around the peak. Other less active fractions can be further purified on either Mono-Q with a shallower gradient or a gel filtration column, such as S-300, from which the contaminants are separated due to their smaller MW. An overall 18-fold purification and a recovery of 67% are achieved. As discussed below, the existence of two elution bands of r-MtL on Q-Sepharose chromatogram is probably due to a differential glycosylation.

The purified r-MtL shows a MW of 100-140 kdal on S-300 gel filtration and a MW of 85 kdal on SDS-PAGE. The increase of r-MtL mobility on SDS-PAGE after deglycosylation suggests that carbohydrates account for 14% of its total mass. Native IEF shows a major band at pI ˜4.2 that is active in ABTS overlay assay.

Directly sequencing the N-terminus of the purified r-MtL from samples either in desalted solution or on PVDF membrane are unsuccessful. However, treatment of r-MtL with pyroglutamate amino peptidase yielded a protein with deblocked N-terminus. This suggests the processing of a propeptide during the maturation of r-MtL, a posttranslational event similar to that of N. crassa laccase but not found in other laccases such as Rhizoctonia solani. The proposed scheme is outlined below. ##STR1##

The spectrum of the blue r-MtL has absorption maxima at 276 and 589 nm.

The activity of the laccase is tested by using either syringaldazine and ABTS as substrates. Expressed as per Abs276 or per mg, the laccase has a value of 20 or 45 units for SOU at pH 6.5, respectively. The LACU assay yields a value of 10 or 22 units per Abs276 or per mg.

The pH profile of r-MtL activity is quite close to that of the wild type, with an optimal pH of 6.5. The upper temperature limit for retaining full activity after a 20 minute preincubation observed for r-MtL is approximately 60° C. The purified r-MtL shows no activity loss over a 5 week storage frozen in Q-sepharose elution buffer at -20° C.

When comparing the two forms of r-MtL obtained from the fermentor broth isolated on Q-Sepharose, there are no significant differences seen in terms of SDS-PAGE, native PAGE, native IEF, S-300 gel filtration, UV-visible spectrum, specific activity towards syringaldazine and ABTS, and deblocked N-terminus sequencing measurements. Likely, the different elution pattern on Q-Sepharose arises from some sort of differential glycosylation.

IV. USE OF MYCELIOPHTHORA LACCASE IN DYEING HAIR

The dyeing effect of Myceliophthora laccase is tested on various dye precursors and further on 0.1% p-phenylenediamine compared with a number of modifiers.

Materials:

Dye precursors

0.1% p-phenylene-diamine in 0.1M K-phosphate buffer, pH=7.0) 0.1% o-aminophenol in 0.1M K-phosphate buffer, pH-=7.0)

Enzymes

Recombinant Myceliophthora thermophila laccase, 16 LACU/ml (in final dye solution).

Equipment

Datacolor Textflash 2000 (CIE-Lab)

Assessment of the hair color

The quantitative color of the hair tresses is determined on a Datacolor Textflash 2000 by the use of CIE-Lab parameters L* ("0"=black and "100"=white) combined with a* ("-"=green and "+"=red).

Results

Dyeing effect

Tresses of blond European hair (1 gram) are used for testing Myceliophthora thermophila laccase in the context of oxidative hair dyeing. p-phenylene diamine and o-aminophenol are used as the dye precursors.

Hair dyeing

4 ml dye precursor solution is mixed with 1 ml laccase on a Whirley mixer, applied to the hair tresses and kept at 30° C. for 60 minutes. The hair tresses are then rinsed with running water for about 3 minutes, pressed between two fingers, combed, and air dried.

The results of the dyeing effect test are displayed below in Table 1 and 2.

                  TABLE 1                                                          ______________________________________                                         o-aminophenol                                                                               enzyme       L*     a*                                            ______________________________________                                         Untreated blond hair                                                                        -            70.3   2.3                                           Laccase      +            57.7   15.3                                          ______________________________________                                          L*: 0 = black, 100 = white                                                     a*: - = green, + = red                                                   

                  TABLE 2                                                          ______________________________________                                         p-phenylenediamine                                                                          enzyme       L*     a*                                            ______________________________________                                         Untreated blond hair                                                                        -            70.3   2.3                                           1.0 ml laccase                                                                              +            29.1   4.1                                           ______________________________________                                          L*: 0 = black, 100 = white                                                     a*: - = green, + = red                                                   

Result of test

From Table 1 and 2 it can be seen that the Myceliophthora thermophila laccase can be used for oxidative dyeing of hair.

Deposit of Biological Materials

The following biological materials have been deposited under the terms of the Budapest Treaty with the Agricultural Research Service Patent Culture Collection, Northern Regional Research Center, 1815 University Street, Peoria, Ill., 61604 on May 25, 1994, and given the following accession number.

    ______________________________________                                         Deposit               Accession Number                                         ______________________________________                                         E. coli JM101 containing pRaMB5                                                                      NRRL B-21261                                             ______________________________________                                    

    __________________________________________________________________________     SEQUENCE LISTING                                                               (1) GENERAL INFORMATION:                                                       (iii) NUMBER OF SEQUENCES: 2                                                   (2) INFORMATION FOR SEQ ID NO:1:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 3192 base pairs                                                    (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: DNA (genomic)                                              (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                              (B) LOCATION: join(586..831, 917..994, 1079..1090, 1193..1264,                 1337..2308, 2456..2524, 2618..3028)                                            (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:                                        GCTAGCTTCTTTGGTCACCGTCGTTTTCGCCCGCCCCCTCCCTCCTTCAACCCCCTGAGT60                 AGTCGGCTAAGCGATCCTCAATCTGGTCTTGTGAGGTCACGTCCTCCAGCAGATGACAGT120                TCATCGAGCGAGTGATCTCCACCACCCAGAAGGGAGGGGGGATGCGCGCATGCTCCAACA180                TCCCTGGTGTCGCTAGAGACGTCGCGGCATCAGCCTTTTCATCACACCGAGCACGTCCAC240                GGACCGGCTCCTTTCACCCCCGCGTCCTCCGGAGGATTGAGTCACGATATTTCGGGATGT300                GGGAAGGGGGAGAGAAAGGAGGGGGGAGGGGCGGAAACATGTTGGATACGAGCTGCGCCC360                CTTTTTCAACATCGAGAACAGGAAGTCGTTGGTGTCGGCCGTAATGTCTATAAAACGAGG420                CTCCTTCTCGTCGTCGACTTGTCTCAGGTTCTCTCTCTCGTCCACACCAAGCCAGTCTTG480                CCTGAGCCACCTGAGCCACCTTCAACTCATCATCTTCAGTCAAGTCGTTCATTGACATTG540                TGTCTCTCTTTCTATCGAGTCGGCTTCCCGGCCCTTCACCACAACATGAAGTCC594                      MetLysSer                                                                      TTCATCAGCGCCGCGACGCTTTTGGTGGGCATTCTCACCCCTAGCGTT642                            PheIleSerAlaAlaThrLeuLeuValGlyIleLeuThrProSerVal                               51015                                                                          GCTGCTGCCCCTCCATCCACCCCTGAGCAGCGCGACCTGCTCGTCCCG690                            AlaAlaAlaProProSerThrProGluGlnArgAspLeuLeuValPro                               20253035                                                                       ATCACGGAGAGGGAGGAGGCAGCCGTGAAGGCTCGCCAGCAGAGCTGC738                            IleThrGluArgGluGluAlaAlaValLysAlaArgGlnGlnSerCys                               404550                                                                         AACACCCCCAGCAACCGGGCGTGCTGGACTGACGGATACGACATCAAC786                            AsnThrProSerAsnArgAlaCysTrpThrAspGlyTyrAspIleAsn                               556065                                                                         ACCGACTACGAAGTGGACAGCCCGGACACGGGTGTTGTTCGGCCG831                               ThrAspTyrGluValAspSerProAspThrGlyValValArgPro                                  707580                                                                         GTGAGTGCTCTCGTTAATTACGCTTCGGCGAGTTGCGCAGATATATTAAATACTGCAAAC891                CTAAGCAGGAGCTGACATGCGACAGTACACTCTGACTCTCACCGAAGTCGAC943                        TyrThrLeuThrLeuThrGluValAsp                                                    8590                                                                           AACTGGACCGGACCTGATGGCGTCGTCAAGGAGAAGGTCATGCTGGTT991                            AsnTrpThrGlyProAspGlyValValLysGluLysValMetLeuVal                               95100105                                                                       AACGTACGGCACCCCTTTTCTTGTCCTAGGATCTGGGTGATGTGCGTCGTTGC1044                      Asn                                                                            CCCTGAGAGAGACTGACCGAGCCTTTGGCTGCAGAATAGTATAATCGTAATTAATT1100                   AsnSerIleIle                                                                   110                                                                            ATACCGCCCTGCCTCCAGCAGCCCCAGCAGCTCGAGAAGGGTATCTGAAGTTAGTCAGGC1160               CTGCTGACCTGACCGGGGCCAACCCACCATAGGGACCAACAATCTTTGCGGAC1213                      GlyProThrIlePheAlaAsp                                                          115                                                                            TGGGGCGACACGATCCAGGTAACGGTCATCAACAACCTCGAGACCAAC1261                           TrpGlyAspThrIleGlnValThrValIleAsnAsnLeuGluThrAsn                               120125130135                                                                   GGCGTATGTCTGCTGCTTGCTCTCTTGCTCTCCTCGTCCGCGACTAATAATAA1314                      Gly                                                                            TATCAACTCGTGTGGAAAACAGACGTCGATCCACTGGCACGGACTGCACCAG1366                       ThrSerIleHisTrpHisGlyLeuHisGln                                                 140145                                                                         AAGGGCACCAACCTGCACGACGGCGCCAACGGTATCACCGAGTGCCCG1414                           LysGlyThrAsnLeuHisAspGlyAlaAsnGlyIleThrGluCysPro                               150155160                                                                      ATCCCGCCCAAGGGAGGGAGGAAGGTGTACCGGTTCAAGGCTCAGCAG1462                           IleProProLysGlyGlyArgLysValTyrArgPheLysAlaGlnGln                               165170175                                                                      TACGGGACGAGCTGGTACCACTCGCACTTCTCGGCCCAGTACGGCAAC1510                           TyrGlyThrSerTrpTyrHisSerHisPheSerAlaGlnTyrGlyAsn                               180185190                                                                      GGCGTGGTCGGGGCCATTCAGATCAACGGGCCGGCCTCGCTGCCGTAC1558                           GlyValValGlyAlaIleGlnIleAsnGlyProAlaSerLeuProTyr                               195200205210                                                                   GACACCGACCTGGGCGTGTTCCCCATCAGCGACTACTACTACAGCTCG1606                           AspThrAspLeuGlyValPheProIleSerAspTyrTyrTyrSerSer                               215220225                                                                      GCCGACGAGCTGGTGGAACTCACCAAGAACTCGGGCGCGCCCTTCAGC1654                           AlaAspGluLeuValGluLeuThrLysAsnSerGlyAlaProPheSer                               230235240                                                                      GACAACGTCCTGTTCAACGGCACGGCCAAGCACCCGGAGACGGGCGAG1702                           AspAsnValLeuPheAsnGlyThrAlaLysHisProGluThrGlyGlu                               245250255                                                                      GGCGAGTACGCCAACGTGACGCTCACCCCGGGCCGGCGGCACCGCCTG1750                           GlyGluTyrAlaAsnValThrLeuThrProGlyArgArgHisArgLeu                               260265270                                                                      CGCCTGATCAACACGTCGGTCGAGAACCACTTCCAGGTCTCGCTCGTC1798                           ArgLeuIleAsnThrSerValGluAsnHisPheGlnValSerLeuVal                               275280285290                                                                   AACCACACCATGACCATCATCGCCGCCGACATGGTGCCCGTCAACGCC1846                           AsnHisThrMetThrIleIleAlaAlaAspMetValProValAsnAla                               295300305                                                                      ATGACGGTCGACAGCCTCTTCCTCGGCGTCGGCCAGCGCTACGATGTC1894                           MetThrValAspSerLeuPheLeuGlyValGlyGlnArgTyrAspVal                               310315320                                                                      GTCATCGAAGCCAGCCGAACGCCCGGGAACTACTGGTTTAACGTCACA1942                           ValIleGluAlaSerArgThrProGlyAsnTyrTrpPheAsnValThr                               325330335                                                                      TTTGGCGGCGGCCTGCTCTGCGGCGGCTCCAGGAATCCCTACCCGGCC1990                           PheGlyGlyGlyLeuLeuCysGlyGlySerArgAsnProTyrProAla                               340345350                                                                      GCCATCTTCCACTACGCCGGCGCCCCCGGCGGCCCGCCCACGGACGAG2038                           AlaIlePheHisTyrAlaGlyAlaProGlyGlyProProThrAspGlu                               355360365370                                                                   GGCAAGGCCCCGGTCGACCACAACTGCCTGGACCTCCCCAACCTCAAG2086                           GlyLysAlaProValAspHisAsnCysLeuAspLeuProAsnLeuLys                               375380385                                                                      CCCGTCGTGGCCCGCGACGTGCCCCTGAGCGGCTTCGCCAAGCGGCCC2134                           ProValValAlaArgAspValProLeuSerGlyPheAlaLysArgPro                               390395400                                                                      GACAACACGCTCGACGTCACCCTCGACACCACGGGCACGCCCCTGTTC2182                           AspAsnThrLeuAspValThrLeuAspThrThrGlyThrProLeuPhe                               405410415                                                                      GTCTGGAAGGTCAACGGCAGCGCCATCAACATCGACTGGGGCAGGCCC2230                           ValTrpLysValAsnGlySerAlaIleAsnIleAspTrpGlyArgPro                               420425430                                                                      GTCGTCGACTACGTCCTCACGCAGAACACCAGCTTCCCACCCGGGTAC2278                           ValValAspTyrValLeuThrGlnAsnThrSerPheProProGlyTyr                               435440445450                                                                   AACATTGTCGAGGTGAACGGAGCTGATCAGGTAAGAAAAAGGGGACCGCA2328                         AsnIleValGluValAsnGlyAlaAspGln                                                 455460                                                                         GGGGTGCTGCTGCAAGTACACCTTGCTCGCCCTCCTGTTCTTCCTTAATAACTACCTCCC2388               AACCCTCCCCCCTAATTAATTCACTTTAAAGGCCGATCAAGACTGACCGAGCCCCCTCTC2448               TTTGCAGTGGTCGTACTGGTTGATCGAGAACGATCCCGGCGCACCTTTC2497                          TrpSerTyrTrpLeuIleGluAsnAspProGlyAlaProPhe                                     465470                                                                         ACCCTACCGCATCCGATGCACCTGCACGTAAGTTGGATACATATATA2544                            ThrLeuProHisProMetHisLeuHis                                                    475480                                                                         TATATATATATACATTGCTTTCCTGGCTCGCTCCCTTAAATAAAATTAAATAACCAAAAA2604               TAACAAAAAAAAGGGCCACGACTTTTACGTGCTGGGCCGCTCGCCCGAC2653                          GlyHisAspPheTyrValLeuGlyArgSerProAsp                                           485490495                                                                      GAGTCGCCGGCATCCAACGAGCGGCACGTGTTCGATCCGGCGCGGGAC2701                           GluSerProAlaSerAsnGluArgHisValPheAspProAlaArgAsp                               500505510                                                                      GCGGGCCTGCTGAGCGGGGCCAACCCTGTGCGGCGGGACGTGACGATG2749                           AlaGlyLeuLeuSerGlyAlaAsnProValArgArgAspValThrMet                               515520525                                                                      CTGCCGGCGTTCGGGTGGGTGGTGCTGGCCTTCCGGGCCGACAACCCG2797                           LeuProAlaPheGlyTrpValValLeuAlaPheArgAlaAspAsnPro                               530535540                                                                      GGCGCCTGGCTGTTCCACTGCCACATCGCCTGGCACGTCTCGGGCGGC2845                           GlyAlaTrpLeuPheHisCysHisIleAlaTrpHisValSerGlyGly                               545550555                                                                      CTGGGCGTCGTCTACCTCGAGCGCGCCGACGACCTGCGCGGGGCCGTC2893                           LeuGlyValValTyrLeuGluArgAlaAspAspLeuArgGlyAlaVal                               560565570575                                                                   TCGGACGCCGACGCCGACGACCTCGACCGCCTCTGCGCCGACTGGCGC2941                           SerAspAlaAspAlaAspAspLeuAspArgLeuCysAlaAspTrpArg                               580585590                                                                      CGCTACTGGCCTACCAACCCCTACCCCAAGTCCGACTCGGGCCTCAAG2989                           ArgTyrTrpProThrAsnProTyrProLysSerAspSerGlyLeuLys                               595600605                                                                      CACCGCTGGGTCGAGGAGGGCGAGTGGCTGGTCAAGGCGTGAGCGAAGG3038                          HisArgTrpValGluGluGlyGluTrpLeuValLysAla                                        610615620                                                                      AGGAAAAAGGAAACAAAGAGGGGGGGGGGGGCTAGTTCCTATTTTTGCTTTTTTTTTTTG3098               TTCTTGTCCTTGTGCTGGCGGTTACCCTGGTAAAGGAGAAGGGGGCCCCAAGTTCGAGTG3158               GGTGTGTGATCGGGTAAATATTATCAAGAGATCT3192                                         (2) INFORMATION FOR SEQ ID NO:2:                                               (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 620 amino acids                                                    (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                           (ii) MOLECULE TYPE: protein                                                    (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:                                        MetLysSerPheIleSerAlaAlaThrLeuLeuValGlyIleLeuThr                               151015                                                                         ProSerValAlaAlaAlaProProSerThrProGluGlnArgAspLeu                               202530                                                                         LeuValProIleThrGluArgGluGluAlaAlaValLysAlaArgGln                               354045                                                                         GlnSerCysAsnThrProSerAsnArgAlaCysTrpThrAspGlyTyr                               505560                                                                         AspIleAsnThrAspTyrGluValAspSerProAspThrGlyValVal                               65707580                                                                       ArgProTyrThrLeuThrLeuThrGluValAspAsnTrpThrGlyPro                               859095                                                                         AspGlyValValLysGluLysValMetLeuValAsnAsnSerIleIle                               100105110                                                                      GlyProThrIlePheAlaAspTrpGlyAspThrIleGlnValThrVal                               115120125                                                                      IleAsnAsnLeuGluThrAsnGlyThrSerIleHisTrpHisGlyLeu                               130135140                                                                      HisGlnLysGlyThrAsnLeuHisAspGlyAlaAsnGlyIleThrGlu                               145150155160                                                                   CysProIleProProLysGlyGlyArgLysValTyrArgPheLysAla                               165170175                                                                      GlnGlnTyrGlyThrSerTrpTyrHisSerHisPheSerAlaGlnTyr                               180185190                                                                      GlyAsnGlyValValGlyAlaIleGlnIleAsnGlyProAlaSerLeu                               195200205                                                                      ProTyrAspThrAspLeuGlyValPheProIleSerAspTyrTyrTyr                               210215220                                                                      SerSerAlaAspGluLeuValGluLeuThrLysAsnSerGlyAlaPro                               225230235240                                                                   PheSerAspAsnValLeuPheAsnGlyThrAlaLysHisProGluThr                               245250255                                                                      GlyGluGlyGluTyrAlaAsnValThrLeuThrProGlyArgArgHis                               260265270                                                                      ArgLeuArgLeuIleAsnThrSerValGluAsnHisPheGlnValSer                               275280285                                                                      LeuValAsnHisThrMetThrIleIleAlaAlaAspMetValProVal                               290295300                                                                      AsnAlaMetThrValAspSerLeuPheLeuGlyValGlyGlnArgTyr                               305310315320                                                                   AspValValIleGluAlaSerArgThrProGlyAsnTyrTrpPheAsn                               325330335                                                                      ValThrPheGlyGlyGlyLeuLeuCysGlyGlySerArgAsnProTyr                               340345350                                                                      ProAlaAlaIlePheHisTyrAlaGlyAlaProGlyGlyProProThr                               355360365                                                                      AspGluGlyLysAlaProValAspHisAsnCysLeuAspLeuProAsn                               370375380                                                                      LeuLysProValValAlaArgAspValProLeuSerGlyPheAlaLys                               385390395400                                                                   ArgProAspAsnThrLeuAspValThrLeuAspThrThrGlyThrPro                               405410415                                                                      LeuPheValTrpLysValAsnGlySerAlaIleAsnIleAspTrpGly                               420425430                                                                      ArgProValValAspTyrValLeuThrGlnAsnThrSerPheProPro                               435440445                                                                      GlyTyrAsnIleValGluValAsnGlyAlaAspGlnTrpSerTyrTrp                               450455460                                                                      LeuIleGluAsnAspProGlyAlaProPheThrLeuProHisProMet                               465470475480                                                                   HisLeuHisGlyHisAspPheTyrValLeuGlyArgSerProAspGlu                               485490495                                                                      SerProAlaSerAsnGluArgHisValPheAspProAlaArgAspAla                               500505510                                                                      GlyLeuLeuSerGlyAlaAsnProValArgArgAspValThrMetLeu                               515520525                                                                      ProAlaPheGlyTrpValValLeuAlaPheArgAlaAspAsnProGly                               530535540                                                                      AlaTrpLeuPheHisCysHisIleAlaTrpHisValSerGlyGlyLeu                               545550555560                                                                   GlyValValTyrLeuGluArgAlaAspAspLeuArgGlyAlaValSer                               565570575                                                                      AspAlaAspAlaAspAspLeuAspArgLeuCysAlaAspTrpArgArg                               580585590                                                                      TyrTrpProThrAsnProTyrProLysSerAspSerGlyLeuLysHis                               595600605                                                                      ArgTrpValGluGluGlyGluTrpLeuValLysAla                                           610615620                                                                      __________________________________________________________________________ 

What we claim is:
 1. A DNA construct comprising a nucleic acid sequence encoding a laccase, wherein the nucleic acid sequence is:(a) a nucleic acid sequence which encodes a laccase with the amino acid sequence of SEQ ID NO:2; or (b) a nucleic acid sequence obtained from a Myceliophthora strain which is capable of hybridizing under high stringency conditions to the nucleic acid sequence of SEQ ID NO:1 or its complementary strand.
 2. The DNA construct of claim 1, wherein the nucleic acid sequence encodes a laccase with the amino acid sequence of SEQ ID NO:2.
 3. The DNA construct of claim 2, wherein the nucleic acid sequence is SEQ ID NO:1.
 4. The DNA construct of claim 1, wherein the nucleic acid sequence is obtained from a Myceliophthora strain and is capable of hybridizing under high stringency conditions to the nucleic acid sequence of SEQ ID NO:1 or its complementary strand.
 5. The DNA construct of claim 4, wherein the nucleic acid sequence is obtained from Myceliophthora thermophila.
 6. A DNA construct comprising a nucleic acid sequence encoding a laccase, wherein the nucleic acid sequence is contained in plasmid pRamB5 contained in Escherichia coli NRRL B-21261.
 7. A recombinant vector comprising a DNA construct of claim
 1. 8. A recombinant host cell comprising a DNA construct of claim
 1. 9. A recombinant host cell comprising a DNA construct of claim
 6. 10. The recombinant cell of claim 8 which is a fungal cell.
 11. The recombinant cell of claim 10 which is an Aspergillus cell.
 12. The recombinant cell of claim 10 which is a Fusarium cell.
 13. The recombinant cell of claim 8 in which the construct is integrated into the host cell genome.
 14. The recombinant cell of claim 8 in which the construct is contained on a vector.
 15. The recombinant cell of claim 8 which comprises a construct containing a sequence encoding the amino acid sequence of SEQ ID NO.
 2. 16. A method for obtaining a laccase, comprising(a) culturing the recombinant host cell of claim 8; and (b) recovering the laccase.
 17. A method for obtaining a laccase, comprising(a) culturing the recombinant host cell of claim 9; and (b) recovering the laccase.
 18. The method of claim 16, wherein the culturing of the recombinant host cell takes place in a medium having at least 0.02 mM copper.
 19. The methdo of claim 17, wherein the culturing of the recombinant host cell takes place in a medium having at least 0.02 mM copper. 